Gang Qin

This inventor holds 16 USPTO granted patents and 24 published patent applications and 3 EPO patents. Top assignees: Genequantum Healthcare (Suzhou) Co., Ltd., Lisure Science (Suzhou) Co., Ltd. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gang Qin. Retrieved from https://idiyas.com/inventor/gang-qin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 24)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 26)

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Jiangsu, CN (2021 - 2024)
Suzhou, CN (2022 - 2024)

Company Filing History:

16 out of 16

Genequantum Healthcare (Suzhou) Co., Ltd.

patents

3 out of 3

Lisure Science (Suzhou) Co., Ltd

patents

where one patent can have more than one assignee

Years Active: 2021-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12485299 - ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF (2025-12-02),

2. 12467103 - LIGASE FUSION PROTEINS AND APPLICATION THEREOF (2025-11-11),

3. 12428616 - Conjugation device and method for producing conjugates (2025-09-30),

4. 12377151 - Immobilized endoglycosidase fusion protein and use thereof (2025-08-05),

5. 12318457 - Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof (2025-06-03),

6. 12012582 - Conjugation device and method for producing conjugates (2024-06-18),

7. 11999748 - Exatecan derivatives, linker-payloads, and conjugates and thereof (2024-06-04),

8. 11911435 - Stable antibody-drug conjugate, preparation method therefor, and use thereof (2024-02-27),

9. 11911434 - Stable antibody-drug conjugate, preparation method therefor, and use thereof (2024-02-27),

10. 11834688 - Ligase fusion proteins and application thereof (2023-12-05),

11. 11826432 - Linkers, conjugates and applications thereof (2023-11-28),

12. 11814394 - Exatecan derivatives, linker-payloads, and conjugates and thereof (2023-11-14),

13. 11717576 - Antibody-immune agonist conjugate and applications thereof (2023-08-08),

14. 11578297 - Conjugation device and method for producing conjugates (2023-02-14),

15. 11453870 - Ligase fusion proteins and application thereof (2022-09-27),

Title: Gang Qin: Innovator in Antibody-Drug Conjugation Technologies

Introduction

Gang Qin is a prominent inventor based in Suzhou, China, known for his significant contributions to the field of biotechnology. With a total of 14 patents to his name, he has made remarkable advancements in the development of conjugation devices and methods for producing conjugates. His work has the potential to revolutionize the way antibody-drug conjugates are created, enhancing therapeutic options in medicine.

Latest Patents

Among his latest patents, Gang Qin has developed a conjugation device and method for producing conjugates. This innovative device includes a flow reactor filled with a support matrix, which contains chromatography beads, fibers, or membranes, along with an immobilized biologic catalyzer, specifically the enzyme ligase. The device is designed to continuously provide reaction fluids, facilitating a conjugation reaction between the first and second moieties of a conjugate under the catalysis of ligase.

Another notable patent involves an immobilized endoglycosidase fusion protein and its use in preparing antibody-drug conjugates. This method allows for site-directed conjugation based on an N-glycosylation site of an antibody's Fc region. The process includes covalently linking an activated donor containing an oxazoline oligosaccharide to an antibody, achieving one-step conjugation through the catalytic action of the endoglycosidase.

Career Highlights

Gang Qin has worked with several companies, including Genequantum Healthcare (Suzhou) Co., Ltd. and Lisure Science (Suzhou) Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Some of his notable coworkers include Cao Lv and Joachim Walter, who have collaborated with him on various projects related to his patents and innovations.

Conclusion

Gang Qin's work in the field of antibody-drug conjugation technologies showcases his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving therapeutic methods, which could have a lasting impact on healthcare.

Profile summary based on public USPTO records.